During the recent annual meeting of the Association of Oncology Social Work, LLS Information Specialist Nikki Yuill, LCSW was awarded the LLS Hematology-Oncology Lifetime Achievement Award. Our Information Specialists are available to provide education, support and resources from 9 AM to 9 PM EST Monday through Friday by chat, phone, email and voicemail. If you have a question or would like to discuss your diagnosis, treatment and/or side effects or need support and resource information, reach out today!
The Association of Oncology Social Work recently held its annual meeting in which recognition of social work excellence was provided through several awards. One of these awards, LLS Hematology-Oncology Lifetime Achievement Award, honors an oncology social worker who has exhibited leadership and support for blood cancers patients and has had ongoing involvement with The Leukemia & Lymphoma Society throughout their career. This year, LLS is proud to announce the Lifetime Achievement Awa...
LLS celebrates its online Community members, now over 15,000 strong. LLS Community launched in 2016 to honor Michael Garil, who was diagnosed with acute lymphoblastic leukemia in 1974 at the age of 7. Throughout his life, Michael dedicated himself to openly sharing his experiences in the hopes of helping others. To continue what Michael started, his parents Ethel and Bernard Garil generously supported the creation of LLS Community in his memory. During the past four years, LLS Community ...
My name is Caitlin McClellan and I was diagnosed with Non-Hodgkin lymphoma in June 2015. I went through six months of chemotherapy and two years of maintenance with Rituxan. I am loving life! I got married in 2017 and went on a wonderful honeymoon to Nashville, Tennessee. While there, we decided to do a Light the Night walk and met Charles Esten! We have done many Light the Night walks. My team name even won some prizes! It is ode to the nodes!
Don't Miss The LLS Inaugural National Blood Cancer Conference-A Free VIRTUAL Educational Conference for Patients, Survivors, Caregivers and Healthcare Professionals. The conference will be held on Saturday, September 12, 2020 beginning at 11:30 am EST (ends 2:45 pm EST) and will feature expert speakers from around the country. This virtual Blood Cancer Conference (BCC) is one of many programs developed by The Leukemia & Lymphoma Society (LLS) to meet the needs of patients, surviv...
As an LLS Clinical Trial Nurse Navigator, Ashley Giacobbi works tirelessly to connect the right patient with the right clinical trial – work that has become increasingly complicated in the COVID-19 era. But recently, she went the extra mile to ensure a patient – a young healthcare worker whose AML had relapsed several times – could access a trial that offered a promising treatment option. The patient had reached out to LLS seeking a trial back in May. Giacobbi identified about 15 ...
Join The Leukemia & Lymphoma Society on Saturday, September 26, 2020 at 9:30 am for the Virtual Georgia Blood Cancer Conference. REGISTER TODAY at www.lls.org/GABCC20! For more information, please contact georgia.bcc@lls.org or 404-720-7838.
Please join your local chapter in the following education programs for patients and caregivers. Surviving and Thriving with Blood Cancer Through a Pandemic A Virtual / Online Education Program August 13, 2020 (NJ) 6:00pm – 7:30pm (ET) https://bit.ly/JTCCAug13 Life Beyond Pediatric Blood Cancer: An Evening of Education & Survivorship A Virtual / Online Education Program August 17, 2020 (IN) 5:30PM – 7:00PM (ET) https://na.eventscloud.com/557560 Eating for Your Needs wi...
The U.S. Food and Drug Administration (FDA) today announced its approval for a breakthrough treatment that will bring the promise of immunotherapy and new hope to thousands of patients diagnosed with mantle cell lymphoma (MCL) whose previous treatments fail to bring them lasting remissions. There are more than 70 subtypes of lymphoma, and MCL is a particularly aggressive form of this blood cancer with a short remission from standard therapies. The median overall survival rate is betwe...
Kymera Therapeutics is a biotech company pioneering an emerging approach to cancer therapy called “targeted protein degradation.” Whereas most targeted therapies inhibit or inactivate the proteins or genes that drive the cancer, targeted protein degradation harnesses the body’s natural system of ridding itself of unwanted, ‘old’ or ‘broken’ components of cells. In March 2020, LLS made a strategic investment in Kymera’s work to treat blood-based cancers through our Therapy Acce...
Labs are eerily quiet. Clinical trials have been paused. Cancer researchers – particularly those who are early in their careers – are facing unprecedented uncertainty. The global COVID-19 pandemic has not only upended every aspect of cancer care for patients and their families, but also halted critical research around the world. In addition to lab closures, many institutions and organizations have been forced to scale back their investments in research, creating unexpected funding shortag...
